Can a patient safely take claritin (loratadine) while taking vascepa (icosapent ethyl) 1 g capsule, olmesartan medoxomil 20 mg tablet, rosuvastatin calcium 40 mg tablet, amlodipine besylate 5 mg tablet, jardiance (empagliflozin) 25 mg tablet, metformin HCl 500 mg tablet, and aspirin 81 mg delayed‑release tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, the patient can safely take Claritin (loratadine) with this medication regimen.

There are no clinically significant drug-drug interactions between loratadine and any of the medications listed (Vascepa, olmesartan, rosuvastatin, amlodipine, Jardiance, metformin, or aspirin).

Key Points

No Interaction with Cardiovascular Medications

The provided evidence extensively addresses drug interactions with statins (rosuvastatin) and cardiovascular agents, but loratadine is not mentioned as an interacting drug in any of the comprehensive guidelines or studies reviewed. The American Heart Association's 2016 scientific statement on statin drug interactions 1 discusses interactions with antiarrhythmics, calcium channel blockers, anticoagulants, and immunosuppressants—but antihistamines like loratadine are notably absent from concern.

Rosuvastatin and Amlodipine Combination is Safe

The patient's current regimen of rosuvastatin 40 mg with amlodipine 5 mg is well-established as safe. There is no evidence of significant interaction when amlodipine is coadministered with rosuvastatin 1. Multiple studies confirm the safety of combining these agents 2, 3, 4.

Loratadine's Pharmacologic Profile

Loratadine is a second-generation antihistamine with minimal drug interaction potential because:

  • It does not significantly inhibit or induce CYP450 enzymes
  • It has minimal effects on cardiac conduction (unlike first-generation antihistamines)
  • It does not interact with P-glycoprotein transport in a clinically meaningful way

Vascepa Considerations

While Vascepa (icosapent ethyl) carries warnings about bleeding risk, particularly with antithrombotic agents 5, loratadine does not affect coagulation or platelet function and poses no additive bleeding risk.

Clinical Recommendation

Proceed with Claritin without dose adjustments. The patient's cardiovascular medication regimen—including the statin, ARB, calcium channel blocker, SGLT2 inhibitor, metformin, and low-dose aspirin—has no pharmacokinetic or pharmacodynamic interactions with loratadine that would compromise safety or efficacy.

Monitoring

Standard monitoring for the patient's existing medications should continue:

  • Blood pressure control with olmesartan and amlodipine
  • Lipid panel for rosuvastatin efficacy
  • Renal function and glucose for Jardiance and metformin
  • No additional monitoring is needed for loratadine addition

References

Related Questions

What are the drug interaction risks and monitoring recommendations for methotrexate when used concomitantly with rosuvastatin (Crestor), spironolactone, perindopril (arginine), and amlodipine (besylate)?
Can a patient taking Skalexin, Ounjaro 7.5 mg subcutaneously weekly, levothyroxine 112 mcg daily, amlodipine 5 mg daily, losartan 25 mg daily, and rosuvastatin (Crestor) 10 mg daily safely take duloxetine (Cymbalta) 30 mg and hydrocodone together?
Can you check for drug interactions between rosuvastatin, diltiazem, and losartan?
For a 75‑year‑old woman taking amlodipine, atenolol, famotidine, empagliflozin (Jardiance), losartan, nifedipine, and rosuvastatin, can I prescribe cetirizine (Zyrtec), topical diclofenac, and a muscle relaxant such as cyclobenzaprine (Flexeril) or metaxalone?
Is the patient’s allergic reaction to both atorvastatin and rosuvastatin due to a true statin class allergy (cross‑reactivity)?
Is there a toxic level for thymoquinone, the active ingredient in black seed oil?
Is there evidence supporting the addition of brexpiprazole (Rexulti) to a patient already receiving aripiprazole (Abilify)?
What is the most likely unifying diagnosis for a patient with markedly elevated anti‑Saccharomyces cerevisiae IgA and IgG antibodies, fecal calprotectin approximately 500 µg/g, ANA 1:1280 speckled pattern, thyroglobulin antibody around 1000 IU/mL, severe fatigue, low vitamin D, borderline low vitamins A, E, and K, and intermittent anti‑gliadin antibody positivity?
In a patient with mildly positive anti‑SSB (Ro) antibody and joint pain but negative ANA and other autoimmune serologies, what is the recommended evaluation and management?
What is the dosing schedule, indications, contraindications, and monitoring for Vivitrol (extended‑release naltrexone) injection?
What vaginal pH range is associated with a yeast infection (candidiasis)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.